<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Arthritis Res Ther</journal-id><journal-title-group><journal-title>Arthritis Research &#x00026; Therapy</journal-title></journal-title-group><issn pub-type="ppub">1478-6354</issn><issn pub-type="epub">1478-6362</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">2834038</article-id><article-id pub-id-type="publisher-id">ar1560</article-id><article-id pub-id-type="doi">10.1186/ar1560</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Regulatory T-cell defect in the arthritis-susceptible DBA/1 mouse</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Fairchild</surname><given-names>SP</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Schenk</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Doffinger</surname><given-names>R</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Hall</surname><given-names>FC</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Department of Clinical Medicine, University of Cambridge, UK</aff><aff id="I2"><label>2</label>Department of Clinical Immunology and Biochemistry, Addenbrooke's Hospital, Cambridge, UK</aff><pub-date pub-type="ppub"><year>2005</year></pub-date><pub-date pub-type="epub"><day>17</day><month>2</month><year>2005</year></pub-date><volume>7</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">25th European Workshop for Rheumatology Research</named-content><named-content content-type="supplement-sponsor">The organizer would like to thank the following companies who have generously supported the meeting: Abbott Immunology (Main sponsor), Bristol-Myers Squibb, Schering-Plough, Wyeth, AstraZeneca, MSD, Amgen</named-content></supplement><fpage>P39</fpage><lpage>P39</lpage><history><date date-type="received"><day>11</day><month>1</month><year>2005</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2005 BioMed Central Ltd</copyright-statement><copyright-year>2005</copyright-year><copyright-holder>BioMed Central Ltd</copyright-holder></permissions><conference><conf-date>24&#x02013;27 February 2005</conf-date><conf-name>25th European Workshop for Rheumatology Research</conf-name><conf-loc>Glasgow, UK</conf-loc></conference></article-meta></front><body><sec><title>Background</title><p>DBA/1 mice are susceptible to collagen-induced arthritis and to low-grade spontaneous inflammatory arthritis in elderly males. CD4<sup>+</sup>CD25<sup>+ </sup>T cells have been implicated in the suppression of arthritis in the susceptible DBA/1 strain [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>] and in patients with rheumatoid arthritis [<xref ref-type="bibr" rid="B3">3</xref>]. We have studied the function of the CD4<sup>+</sup>CD25<sup>+ </sup>T-cell subset in DBA/1 and arthritis-non-susceptible C57Bl/6 male mice.</p></sec><sec sec-type="methods"><title>Methods</title><p>The frequencies of CD4<sup>+</sup>CD25<sup>+ </sup>T cells were assessed in lymph nodes and the spleen of DBA/1 and C57Bl/6 mice by FACS analysis. Spleens were harvested from adult male DBA/1 and BALB/c mice. CD4<sup>+</sup>CD25<sup>+ </sup>and CD4<sup>+</sup>CD25<sup>- </sup>T cells were purified using Miltenyi reagents and a VarioMACS. Proliferation assays in response to either Concanavalin A (1 &#x003bc;g/ml) or soluble anti-CD3 (0.1&#x02013;10 &#x003bc;g/ml) were performed using 5e4 CD4<sup>+</sup>CD25<sup>- </sup>cells with 1e5 irradiated adherent splenocytes as antigen-presenting cells. Co-culture of CD4<sup>+</sup>CD25<sup>+ </sup>and CD4<sup>+</sup>CD25<sup>- </sup>T cells in a 1:1 ratio was used to assess suppression. Cytokines (IL-2, interferon gamma, IL-4, IL-10, tumour necrosis factor alpha, IL-6, IL-17, IL-15) were measured in the tissue culture supernatant after 36 hours incubation. Proliferation was measured by [<sup>3</sup>H]-thymidine incorporation. Suppression ratios (SRs) were calculated as follows: SR = (response from CD25<sup>+</sup>:CD25<sup>- </sup>T-cell coculture) / (response from CD25<sup>- </sup>T cells alone). SRs in DBA/1 and C57Bl/6 mice were compared using Student's <italic>t </italic>test.</p></sec><sec><title>Results</title><p>The frequency of CD4<sup>+</sup>CD25<sup>+ </sup>T cells was comparable in the spleen and lymph nodes of DBA/1 and C57Bl/6 mice. SRs were higher (i.e. less suppression) in proliferation assays from DBA/1 mice compared with C57Bl/6 mice, which were stimulated with anti-CD3 (<italic>P </italic>= 0.03). DBA/1 cultures were generally associated with higher cytokine levels. Cytokine SRs were higher (i.e. less suppression) for DBA/1 compared with C57Bl/6 cultures for IL-6 and IL-17. SRs were lower (i.e. more suppression) for DBA/1 compared with C57Bl/6 cultures for IL-4 and IL-10.</p></sec><sec><title>Conclusions</title><p>The arthritis-susceptible DBA/1 mouse strain appears to have a functional defect in the CD4<sup>+ </sup>CD25<sup>+ </sup>T-cell compartment. IL-4 and IL-10 are efficiently suppressed by CD4<sup>+</sup>CD25<sup>+ </sup>T cells. Suppression of IL-6 and IL-17 appears to be defective. This may partly explain the susceptibility of DBA/1 mice to erosive arthritis.</p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Morgan</surname><given-names>ME</given-names></name><name><surname>Sutmuller</surname><given-names>RP</given-names></name><name><surname>Witteveen</surname><given-names>HJ</given-names></name><name><surname>van Duivenvoorde</surname><given-names>LM</given-names></name><name><surname>Zanelli</surname><given-names>E</given-names></name><name><surname>Melief</surname><given-names>CJ</given-names></name><name><surname>Snijders</surname><given-names>A</given-names></name><name><surname>Offringa</surname><given-names>R</given-names></name><name><surname>de Vries</surname><given-names>RR</given-names></name><name><surname>Toes</surname><given-names>RE</given-names></name><article-title>CD25<sup>+ </sup>cell depletion hastens the onset of severe disease in collagen-induced arthritis</article-title><source>Arthritis Rheum</source><year>2003</year><volume>48</volume><fpage>1452</fpage><lpage>1460</lpage><pub-id pub-id-type="doi">10.1002/art.11063</pub-id><pub-id pub-id-type="pmid">12746920</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="other"><name><surname>Loughry</surname><given-names>A</given-names></name><name><surname>Fairchild</surname><given-names>S</given-names></name><name><surname>Athanasou</surname><given-names>N</given-names></name><name><surname>Edwards</surname><given-names>J</given-names></name><name><surname>Hall</surname><given-names>FC</given-names></name><article-title>Inflammatory arthritis and dermatitis in thymectomized CD25<sup>+ </sup>cell depleted adult mice</article-title><source>Rheumatology</source><year>2005</year><comment> in press </comment></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Ehrenstein</surname><given-names>MR</given-names></name><name><surname>Evans</surname><given-names>JG</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Moore</surname><given-names>S</given-names></name><name><surname>Warnes</surname><given-names>G</given-names></name><name><surname>Isenberg</surname><given-names>DA</given-names></name><name><surname>Mauri</surname><given-names>C</given-names></name><article-title>Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy</article-title><source>J Exp Med</source><year>2004</year><volume>200</volume><fpage>277</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1084/jem.20040165</pub-id><pub-id pub-id-type="pmid">15280421</pub-id></mixed-citation></ref></ref-list></back></article>